[1]
Larussa, T., Basile, A., Palleria, C., Iannelli, C., Vero, A., Giubilei, L., De Sarro, C., Suraci, E., Marasco, R., Imeneo, M., Russo, E., Abenavoli, L., De Sarro, G. and Luzza, F. 2021. Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series. Medicine and Pharmacy Reports. 94, 3 (Jun. 2021), 289-297. DOI:https://doi.org/10.15386/mpr-1897.